264 related articles for article (PubMed ID: 18325835)
21. Clonal expansion within clonal complex 2 and spread of vancomycin-resistant plasmids among different genetic lineages of Enterococcus faecalis from Portugal.
Freitas AR; Novais C; Ruiz-Garbajosa P; Coque TM; Peixe L
J Antimicrob Chemother; 2009 Jun; 63(6):1104-11. PubMed ID: 19329507
[TBL] [Abstract][Full Text] [Related]
22. [Epidemiology of the infection by resistant Gram-positive microorganisms].
Cercenado E
Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():6-9. PubMed ID: 27608305
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative.
Draghi DC; Benton BM; Krause KM; Thornsberry C; Pillar C; Sahm DF
J Antimicrob Chemother; 2008 Jul; 62(1):116-21. PubMed ID: 18424792
[TBL] [Abstract][Full Text] [Related]
24. ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries.
Jones RN; Kohno S; Ono Y; Ross JE; Yanagihara K
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):191-201. PubMed ID: 19500528
[TBL] [Abstract][Full Text] [Related]
25. [Mechanisms behind the development of antibiotic resistant bacteria].
Gaustad P
Tidsskr Nor Laegeforen; 2001 Oct; 121(26):3090-4. PubMed ID: 11757446
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
Rossolini GM; Mantengoli E
Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
[TBL] [Abstract][Full Text] [Related]
27. Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen.
Top J; Willems R; Bonten M
FEMS Immunol Med Microbiol; 2008 Apr; 52(3):297-308. PubMed ID: 18279340
[TBL] [Abstract][Full Text] [Related]
28. Coagulase-negative staphylococcus and enterococcus as predominant pathogens in liver transplant recipients with Gram-positive coccal bacteremia.
Shi SH; Kong HS; Jia CK; Xu J; Zhang WJ; Wang WL; Shen Y; Zhang M; Zheng SS
Chin Med J (Engl); 2010 Aug; 123(15):1983-8. PubMed ID: 20819529
[TBL] [Abstract][Full Text] [Related]
29. Large clonal outbreak of multidrug-resistant CC17 ST17 Enterococcus faecium containing Tn5382 in a Spanish hospital.
Valdezate S; Labayru C; Navarro A; Mantecón MA; Ortega M; Coque TM; García M; Saéz-Nieto JA
J Antimicrob Chemother; 2009 Jan; 63(1):17-20. PubMed ID: 19001448
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance study.
Kuo LC; Yu CJ; Kuo ML; Chen WN; Chang CK; Lin HI; Chen CC; Lu MC; Lin CH; Hsieh WF; Chen LW; Chou Y; Huang MS; Lee CH; Chen SC; Thai SL; Chen PC; Chen CH; Tseng CC; Chen YS; Hsiue TR; Hsueh PR
Int J Antimicrob Agents; 2008 May; 31(5):420-6. PubMed ID: 18358701
[TBL] [Abstract][Full Text] [Related]
31. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
Jones RN; Kirby JT; Rhomberg PR
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):203-13. PubMed ID: 18329835
[TBL] [Abstract][Full Text] [Related]
32. Development and spread of bacterial resistance to antimicrobial agents: an overview.
Tenover FC
Clin Infect Dis; 2001 Sep; 33 Suppl 3():S108-15. PubMed ID: 11524705
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
[TBL] [Abstract][Full Text] [Related]
34. The changing epidemiology of resistance.
Hawkey PM; Jones AM
J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i3-10. PubMed ID: 19675017
[TBL] [Abstract][Full Text] [Related]
35. Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST).
Bouchillon SK; Iredell JR; Barkham T; Lee K; Dowzicky MJ
Int J Antimicrob Agents; 2009 Feb; 33(2):130-6. PubMed ID: 18995992
[TBL] [Abstract][Full Text] [Related]
36. Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology.
Hershberger E; Donabedian S; Konstantinou K; Zervos MJ
Clin Infect Dis; 2004 Jan; 38(1):92-8. PubMed ID: 14679454
[TBL] [Abstract][Full Text] [Related]
37. Clinical isolates of Staphylococcus aureus from the Arkhangelsk region, Russia: antimicrobial susceptibility, molecular epidemiology, and distribution of Panton-Valentine leukocidin genes.
Vorobieva V; Bazhukova T; Hanssen AM; Caugant DA; Semenova N; Haldorsen BC; Simonsen GS; Sundsfjord A
APMIS; 2008 Oct; 116(10):877-87. PubMed ID: 19132981
[TBL] [Abstract][Full Text] [Related]
38. Reversal of resistance in microorganisms by help of non-antibiotics.
Kristiansen JE; Hendricks O; Delvin T; Butterworth TS; Aagaard L; Christensen JB; Flores VC; Keyzer H
J Antimicrob Chemother; 2007 Jun; 59(6):1271-9. PubMed ID: 17403708
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
Sparo MD; Jones DG; Sánchez Bruni SF
Chemotherapy; 2009; 55(4):270-7. PubMed ID: 19494489
[TBL] [Abstract][Full Text] [Related]
40. Reversal of antibiotic resistance in Gram-positive bacteria by the antihistaminic azelastine.
El-Nakeeb MA; Abou-Shleib HM; Khalil AM; Omar HG; El-Halfawy OM
APMIS; 2012 Mar; 120(3):215-20. PubMed ID: 22339679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
